Responder analyses for anti-amyloid immunotherapies for Alzheimer’s disease: a paradigm shift by regulatory authorities is urgently needed

Detalles Bibliográficos
Autores principales: Salemme, Simone, Ancidoni, Antonio, Vanacore, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612473/
https://www.ncbi.nlm.nih.gov/pubmed/37901042
http://dx.doi.org/10.1093/braincomms/fcad276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612473/
https://www.ncbi.nlm.nih.gov/pubmed/37901042
http://dx.doi.org/10.1093/braincomms/fcad276

Ejemplares similares